How GSK Reduces Errors and Improves Manufacturing Execution with Digitalization

Speed to market remains a key driver for the digitalization of long-standing paper-based processes in drug manufacturing. Bottlenecks such as manual execution and review—all associated with bloated documentation—prevent companies from aligning with the FDA’s vision for advanced manufacturing to achieve continuous improvement. Manufacturers like GlaxoSmithKline (GSK) are embracing Pharma 4.0 and paperless technologies to help bring quality medicines to patients more quickly.

 

In this on-demand webinar, Andrew Jenkins, Product Director from GSK, and Craig Resnick, VP of Consulting from ARC, discuss:

  • Challenges and benefits of switching from paper-based to digital operations 
  • Solutions that enable pharma manufacturers to digitalize processes such as batch manufacturing execution
  • How digitalization processes across the value chain meet evolving business demands 

 

Watch this on-demand webinar to learn more about the latest technologies that improve usability, reduce risk and ensure compliance. 

How GSK Reduces Errors and Improves Manufacturing Execution with Digitalization

Why we collect this data

AspenTechは、当社の事業、可能な限り最善の製品やカスタマーサービスのご提供、そして全体的なユーザエクスペリエンスに関わるさまざまな理由でお客様の個人データを収集および処理する場合があります。当社はお客様の個人データを使用して適宜、アンケートや調査の管理、契約サービスの正確な提供、イベントへの登録、お客様の好みの理解、および不正または不正な活動の検出と防止を行う場合があります。個人データの収集と処理の詳細については、こちらからAspenTechのプライバシーおよびセキュリティポリシーを参照してください。

How GSK Reduces Errors and Improves Manufacturing Execution with Digitalization

Hello . If this is not you

Thank you for viewing this on-demand webinar

If you weren't redirected, click here